Pfizer | PFE - Capitalización De Mercado





Capitalización De Mercado Cambio Fecha
AbbVie USD 384.69B 19.14B 2026-03
Abbott USD 175.87B 17.82B 2026-07
ALKERMES USD 5.88B 1.26B 2026-03
Amgen USD 189.89B 13.64B 2026-03
AstraZeneca USD 301.25B 13.1B 2026-03
Bayer EUR 38.69B 2.33B 2026-03
Biogen USD 26.9B 1.09B 2026-03
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Drreddys Laboratories INR 2.41B 8.66B 2026-07
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 172.99B 20.71B 2026-03
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Glaxosmithkline GBP 108.55B 736M 2026-07
J&J USD 602.98B 8.38B 2026-07
Merck USD 297.1B 35.84B 2026-03
Neurocrine Biosciences USD 13.25B 890M 2026-03
Novartis USD 257.14B 50.62B 2026-07
Novartis USD 319.89B 31.63B 2026-07
Pacira USD 915M 149M 2026-03
Perrigo USD 1.31B 604M 2026-03
Pfizer USD 153.81B 12.24B 2026-03
Phibro Animal Health USD 1.51B 126M 2025-12
Prestige Brands USD 2.8B 161M 2026-03
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Roche Holding CHF 235.82B 34.18B 2026-07
Sanofi EUR 100.27B 605.48M 2026-03
Sanofi EUR 108.52B 5B 2026-07
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Zoetis USD 49.71B 5.74B 2026-03